COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,941 Articles (22,604 medRxiv, 8,337 bioRxiv)

Most recent first Previous |  Page 2804: Articles 28031-28040  | Next

Benchmarking the CoVID-19 pandemic across countries and states in the U.S.A. under heterogeneous testing
Asahi, K., Undurraga, E. A., Wagner, R.
10.1101/2020.05.01.20087882 — Posted: 2020-05-06
Incorporating and Addressing Testing Bias Within Estimates of Epidemic Dynamics for SARS-CoV-2
Suhail, Y., Afzal, J., Kshitiz
10.1101/2020.05.02.20088120 — Posted: 2020-05-06
Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCOV RT-PCR assay for the qualitative detection of SARS-CoV-2 from upper respiratory tract specimens
Moore, N. M., Li, H., Schejbal, D., Lindsley, J., Hayden, M.
10.1101/2020.05.02.20088740 — Posted: 2020-05-06
Potential biases arising from epidemic dynamics in observational seroprotection studies
Kahn, R., Kennedy-Shaffer, L., Grad, Y., Robins, J. M., Lipsitch, M.
10.1101/2020.05.02.20088765 — Posted: 2020-05-06
Predictive Model with Analysis of the Initial Spread of COVID-19 in India
Ghosh, S.
10.1101/2020.05.02.20088997 — Posted: 2020-05-06
COVID-19 in Children with Brain-Based Developmental Disabilities: A Rapid Review
Dugas, M., Carnovale, V., Poirier, A.-A., Mailot, B., Skidmore, B., Faust, L., Costello, C., Thomson, D., Majnemer, A., Goldowitz, D., Miller, S., LeBlanc, A.
10.1101/2020.05.01.20088021 — Posted: 2020-05-06
A mathematical model to investigate the transmission of COVID-19 in the Kingdom of Saudi Arabia
Alshammari, F. S.
10.1101/2020.05.02.20088617 — Posted: 2020-05-06 Discussion: Offsite
Updated estimates of comorbidities associated with risk for COVID-19 complications based on US data
Adams, M. L., Grandpre, J., Katz, D. L.
10.1101/2020.05.02.20088781 — Posted: 2020-05-06
Simulations of the spread of COVID-19 and control policies in Tunisia
Ben Miled, S., Kebir, A.
10.1101/2020.05.02.20088492 — Posted: 2020-05-06
Management and Outcomes of ST-segment Elevation Myocardial Infarction During Coronavirus 2019 Pandemic in a Center with 24/7 Primary Angioplasty Capability: Should We Change Our Practice During Outbreak?
Salarifar, M., Ghavami, M., Poorhosseini, H., Masoudkabir, F., Jenab, Y., Amirzadegan, A., Alidoosti, M., Aghajani, H., Bozorgi, A., Hosseini, K., Lotfi-Tokaldany, M., Mortazavi, S. H., Aein, A., Ahmadian, T., Sadeghian, S.
10.1101/2020.05.02.20088302 — Posted: 2020-05-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).